Endogenous retroviral long terminal repeats of the HLA-DQ region are associated with susceptibility to insulin-dependent diabetes mellitus

Human Immunology

Volumn 50, Issue 2, 1996, Pages 103-110

  Badenhoop, K ^a,b   Tonjes R R ^c   Rau, H ^a   Donner, H ^a   Rieker, W ^a   Braun, J ^a   Herwig, J ^b   Mytilineos, J ^d   Kurth, R ^c   Usadel, K H ^a  

^a Centre of Internal Medicine   (Germany)

^b UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^c PAUL EHRLICH INSTITUT   (Germany)

^d UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HLA DQ ANTIGEN;

ARTICLE; CONTROLLED STUDY; DNA DETERMINATION; FAMILY STUDY; GENETIC RISK; GENETIC SUSCEPTIBILITY; HAPLOTYPE; HLA SYSTEM; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LONG TERMINAL REPEAT; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

EID: 0030271327     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/0198-8859(96)00146-2     Document Type: Article

References (40)

1. 1. Atkinson MA, MacLaren NK: The pathogenesis of insulin-dependent diabetes mellitus. N Engl J Med 331:1428, 1994.
2. 2. Davies JL, Kawaguchi Y, Bennett ST, Copeman JB, Cordell HJ, Pritchard LE, Reed PW, Gough SCL, Jenkins SC, Palmer SM, Balfour KM, Rowe BR, Farrall M, Barnett AH, Bain SC, Todd JA: A genome-wide search for human type 1 diabetes susceptibility genes. Nature 371: 130, 1994.
3. 3. Hashimoto L, Habita C, Beressi JP, Delepine M, Besse C, Cambon-Thomsen A, Deschamps I, Rotter JI, Djoulah S, James MR, Froguel P, Weissenbach J, Lathrop GM, Julier C: Genetic mapping of a susceptibility locus for insulin-dependent diabetes mellitus on chromosome 11q. Nature 371:161, 1994.
4. 4. Todd JA, Acha-Orbea H, Bell JI, Chao N, Fronek Z, Jacob CO, McDermott M, Sinha AA, Timmermann L, Steinmann L, McDevitt HO: A molecular basis for MHC class II-associated autoimmunity. Science 240:1003, 1988.
5. 5. Morel PA, Dorman JS, Todd JA, McDevitt HO, Trucco M: Aspartic acid at position 57 of the HLA-DQ ß chain protects against type I diabetes: a family study. Proc Natl Acad Sci USA 85:8111, 1988.
6. 6. Khalil I, D'Auriol L, Gobet M, Morin L, Lepage V, Deschamps I, Park MS, Degos L, Galibert F, Hors J: A combination of HLA-DQ beta Asp5 7-negative and HLA DQ alpha Arg52 confers susceptibility to insulin-dependent diabetes mellitus. J Clin Invest 85:1315, 1990.
7. 7. Todd JA: Genetic control of autoimmunity in type 1 diabetes. Immunol Today 11:122, 1990.
8. 8. Badenhoop K, Schwarz G, Bingley P, Lewis V, Drummond V, Gale EAM, Bottazzo GF: Restriction fragment length polymorphism (RFLP) analysis of HLA haplotypes in families with type I diabetes mellitus. Tissue Antigens 35:32, 1990.
9. 9. Badenhoop K, Walfish PG, Rau H, Fischer S, Nicolay A, Bogner U, Schleusener H, Usadel KH: Susceptibility and resistance alleles of human leukocyte antigen (HLA) DQA1 and HLA DQB1 are shared in endocrine autoimmune disease. J Clin Endocrinol Metab 80:2112, 1995.
10. 10. Kambhu S, Falldorf P, Lee JS: Endogenous retroviral long terminal repeats within the HLA-DQ locus. Proc Natl Acad Sci USA 87:4927, 1990.
11. 11. Nepom BS, Palmer J, Kim SJ, Hansen JA, Holbeck SL, Nepom GT: Specific genomic markers for the HLA-DQ subregion discriminate between DR4 insulin-dependent diabetes mellitus and DR4 seropositive juvenile rheumatoid arthritis. J Exp Med 164:345, 1986.
12. 12. Ono M, Yasunaga T, Miyata T, Ushikubo H: Nucleotide sequence of human endogenous retrovirus genome related to the mouse mammary tumor virus genome. J Virol 60:589, 1986.
13. 13. Marsh SGE, Bodmer JG: HLA class II nucleotide sequences, 1991. Immunogenetics 33:321, 1991.
14. 14. Khalil I, Deschamps I, Lepage V, Al-Daccak R, Degos L, Hors J: Dose effect of cis-and trans-encoded HLA-DQalpha/beta heterodimers in IDDM susceptibility. Diabetes 41:378, 1992.
15. 15. Picard JK: Single-step allele-specific polymerase chain reaction HLA-DQ genotyping using ARMS primers. Hum Immunol 38:115, 1993.
16. 16. Zetterquist H, Olerup O: Identification of the HLA-DRB1 04, -DRB1 *07, and -DRB1 *09 alleles by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours. Hum Immunol 34:64, 1992.
17. 17. Bodmer JG, Marsh SGE, Albert ED, Bodmer WE, Bontrop RE, Charron D, Dupont B, Erlich HA, Mach B, Mayr WR, Parham P, Sasazuki T, Schreuder GMT, Strominger JL, Svejgaard A, Terasaki PI: Nomenclature for factors of the HLA system, 1995. Tissue Antigens 46:1, 1995.
18. 18. Sheehy MJ, Scharf SJ, Rowe JR, Neme de Gimenez MH, Meske LM, Erlich HA, Nepom BS: A diabetes-susceptible HLA-haplotype is best defined by a combination of HLA-DR and -DQ alleles. J Clin Invest 83:830, 1989.
19. 19. Caillat-Zucman S, Garchon H-J, Timsit J, Assan R, Boitard C, Djilali-Saiah I, Bougneres P, Bach J-F: Age-dependent HLA genetic heterogeneity of type 1 insulin-dependent diabetes mellitus. J Clin Invest 90:2242, 1992.
20. 20. Warram JH, Krolewski AS, Gottlieb MS, Kahn CR: Differences in risk of insulin dependent diabetes in offspring of diabetic mothers and diabetic fathers. N Engl J Med 311:149, 1984.
21. 21. Deschamps I, Hors J, Clerget-Darpoux F, Gardais E, Robert JJ, Marcelli-Berge A, Lestradet H, Dausset J: Excess of maternal HLA-DR3 antigens in HLA DR3,4 positive type 1 (insulin-dependent) diabetic patients. Diabetologia 33:425, 1990.
22. 22. Bain SC, Rowe BR, Barnett AH, Todd JA: Parental origin of diabetes-associated HLA types in sibling pairs with type I diabetes. Diabetes 43:1462, 1994.
23. 23. Mayer WE, O'H Uigin C, Klein J: Resolution of the HLA-DRB6 puzzle: a case of grafting a de novo-generated exon on an existing gene. Proc Natl Acad Sci USA 90: 10720, 1993.
24. 24. Zhu ZB, Hsieh SL, Bentley DR, Campbell RD, Volanakis JE: A variable number of tandem repeat locus within the human complement C2 gene is associated with a retroposon derived from a human endogenous retrovirus. J Exp Med 175:1783, 1992.
25. 25. Iris FJM, Bougueleret L, Prieur S, Caterina D, Primas G, Perrot V, Jurka J, Rodriguez-Tome P, Claverie JM, Dausset J, Cohen D: Dense Alu clustering and a potential new member of the NFkB family within a 90 kilobase HLA class III segment. Nat Genet 3:137, 1993.
26. 26. Dangel AW, Mendoza AR, Baker BJ, Daniel CM, Carroll MC, Wu L-C, Yu CY: The dichotomous size variation of human complement C4 genes is mediated by a novel family of endogenous retroviruses, which also establishes species-specific genomic patterns among old world primates. Immunogenetics 40:425, 1994.
27. 27. Svensson A-C, Setterblad N, Siurdardottir S, Rask L, Andersson G: Primate DRB genes from the DR3 and DR8 haplotypes contain ERV9 LTR elements at identical positions. Immunogenetics 41:74, 1995.
28. 28. Arvidsson A-K, Svensson A-C, Widmark E, Andersson G, Rask L, Larhammar D: Characterization of three separated exons in the HLA class II region of the human major histocompatibility complex. Hum Immunol 42:254, 1995.
29. 29. Leib-Mösch C, Haltmeier M, Werner T, Geigl E-M, Brack-Werner R, Francke U, Erfle V, Hehlmann R: Genomic distribution and transcription of solitary HERV-K LTRs. Genomics 18:261, 1993.
30. 30. Ono M: Molecular cloning and long terminal repeat sequences of human endogenous retrovirus genes related to types A and B retrovirus genes. J Virol 58:937, 1986.
31. 31. Kazazian HH, Wong C, Youssouffian H, Scott AF, Phillips DG, Antonarakis SE: Haemophilia A resulting from de novo insertion of L1 sequences represents a novel mechanism for mutation in man. Nature 332:164, 1988.
32. 32. Dombroski BA, Mathias SL, Nanthakumar E, Scott AF, Kazazian HH: Isolation of an active human transposable element. Science 254:1805, 1991.
33. 33. Sauter M, Schommer S, Kremmer E, Remberger K, Dölken G, Lemm I, Buck M, Best B, Neumann-Haefelin D, Mueller-Lantzsch N: Human endogenous recrovirus K10: Expression of Gag protein and detection of antibodies in patients with seminomas. J Virol 69:414, 1995.
34. 34. Löwer R, Boller K, Hasenmaier B, Korbmacher C, Mueller-Lantzsch N, Löwer J, Kurth R: Identification of human endogenous retroviruses with complex mRNA expression and particle formation. Proc Natl Acad Sci USA 90:4480, 1993.
35. 35. Kato M, Pfeifer-Ohlsson S, Larsson E, Rydnert J, Ohlsson R, Cohen M: Tissue-specific expression of human provirus ERV3 mRNA in human placenta: Two of the three ERV3 mRNAs contain human cellular sequences. J Virol 61: 2182, 1987.
36. 36. Kobr M, Reith W, Herrero-Sanchez C, Mach B: Two DNA-binding proteins discriminate between the promoters of different members of the major histocompatibility complex class II multigene family. Mol Cell Biol 10:965, 1990.
37. 37. Choi S-Y, Faller DV: The long terminal repeats of a murine retrovirus encode a trans-activator for cellular genes. J Biol Chem 269:19691, 1995.
38. 38. Wu J, Zhou T, He J, Mountz JD: Autoimmune disease in mice due to integration of an endogenous retrovirus in an apopotosis gene. J Exp Med 178:461, 1993.
39. 39. Acha-Orbea H, Palmer E: Mls - a retrovirus exploits the immune system. Immunol Today 12:356, 1991.
40. 40. Conrad B, Weidmann E, Trucco G, Rudert WA, Behboo R, Ricordi C, Rodriquez-Rilo H, Finegold D, Trucco M: Evidence for superantigen involvement in insulin-dependent diabetes aetiology. Nature 371:351, 1994.